Business August 8, 2020
Takeda loses battle to stop Mylan from selling generic gout drug
Takeda Pharmaceuticals (NYSE: TAK) failed to stop Mylan (NASDAQ: MYL) from selling a generic version of its Colcrys, a treatment…
FOLLOW US
Recent Posts
Arizona
January 11, 2025
Kelly Warner Law Firm Blames USA Herald for Arizona Bar Investigation
Arizona
December 12, 2024
Arizona Bar Opens Investigation on Attorney Aaron Kelly
America
March 19, 2026
USPS to Raise Prices Amid $9 Billion Loss
America
March 19, 2026
Mississippi $9.8M Downtown Projects Award Boosts 26 Communities
America
March 19, 2026
US F-35 Emergency Landing After Suspected Iranian Strike
America
March 19, 2026
US States Sue Trump EPA Over Climate Rollback
America
March 19, 2026